Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure
- PMID: 8025996
- DOI: 10.1161/01.cir.90.1.195
Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure
Abstract
Background: B-type or brain natriuretic peptide (BNP) is a novel natriuretic peptide secreted from the heart that forms a peptide family with A-type or atrial natriuretic peptide (ANP), and its plasma level has been shown to be increased in patients with congestive heart failure. This study was designed to examine the sources and mechanisms of the secretion of BNP in comparison with those of ANP in control subjects and in patients with heart failure.
Methods and results: We measured the plasma levels of BNP as well as ANP in 16 patients with dilated cardiomyopathy (11 men and 5 women; mean age, 59 years) and 18 control subjects (9 men and 9 women; mean age, 54 years) by sampling blood from the femoral vein, the aortic root, the anterior interventricular vein (AIV), and the coronary sinus using the newly developed immunoradiometric assay systems. In the control subjects, there was no significant difference in the plasma ANP level between the aortic root and the AIV (24.0 +/- 5.2 pg/mL versus 32.2 +/- 17.0 pg/mL), but there was a highly significant step-up of the level between the AIV and the coronary sinus (32.2 +/- 17.0 pg/mL versus 371.4 +/- 111.1 pg/mL, P < .001). In contrast, there was a significant step-up of the plasma BNP level between the aortic root and the AIV (8.6 +/- 6.4 pg/mL versus 19.0 +/- 11.5 pg/mL, P < .01) but not between the AIV and the coronary sinus (19.0 +/- 11.5 pg/mL versus 28.8 +/- 14.0 pg/mL). On the other hand, in patients with dilated cardiomyopathy, there was a significant step-up in the plasma ANP level between the aortic root and the AIV (280.6 +/- 183.7 pg/mL versus 612.3 +/- 431.6 pg/mL, P < .01) and between the AIV and the coronary sinus (612.3 +/- 431.6 pg/mL versus 1229.0 +/- 772.7 pg/mL, P < .01). There was a significant step-up in the plasma BNP level between the aortic root and the AIV (268.4 +/- 293.2 pg/mL versus 511.6 +/- 458.1 pg/mL, P < .01) but not between the AIV and the coronary sinus (511.6 +/- 458.1 pg/mL versus 529.7 +/- 455.3 pg/mL) in patients with dilated cardiomyopathy. The arteriovenous difference at the AIV of the plasma level of BNP had a significant positive correlation with left ventricular end-systolic volume index (r = 0.859, P < .001) and a significant negative correlation with left ventricular ejection fraction (r = -.735, P < .001).
Conclusions: We conclude that (1) BNP is secreted mainly from the left ventricle in normal adult humans as well as in patients with left ventricular dysfunction, whereas ANP is secreted from atria in normal adult humans and also from the left ventricle in patients with left ventricular dysfunction; (2) secretion of BNP as well as ANP from the left ventricle increases in proportion to the severity of the left ventricular dysfunction, suggesting that the secretions of ANP and BNP from the left ventricle are regulated mainly by wall tension of the left ventricle; and (3) the peripheral plasma levels of ANP and BNP reflect the secretion rate of these hormones from the left ventricle and may be used as a marker of the degree of left ventricular dysfunction in patients with left ventricular dysfunction.
Similar articles
-
Atrial and brain natriuretic peptides: Hormones secreted from the heart.Peptides. 2019 Jan;111:18-25. doi: 10.1016/j.peptides.2018.05.012. Epub 2018 May 31. Peptides. 2019. PMID: 29859763 Review.
-
Different secretion patterns of atrial natriuretic peptide and brain natriuretic peptide in patients with congestive heart failure.Circulation. 1993 Feb;87(2):464-9. doi: 10.1161/01.cir.87.2.464. Circulation. 1993. PMID: 8425293
-
Effects of exercise on plasma level of brain natriuretic peptide in congestive heart failure with and without left ventricular dysfunction.Am Heart J. 1995 Jan;129(1):139-45. doi: 10.1016/0002-8703(95)90054-3. Am Heart J. 1995. PMID: 7817907
-
Brain natriuretic peptide as a novel cardiac hormone in humans. Evidence for an exquisite dual natriuretic peptide system, atrial natriuretic peptide and brain natriuretic peptide.J Clin Invest. 1991 Apr;87(4):1402-12. doi: 10.1172/JCI115146. J Clin Invest. 1991. PMID: 1849149 Free PMC article.
-
[Natriuretic peptide family].Nihon Naibunpi Gakkai Zasshi. 1992 Mar 20;68(3):134-42. doi: 10.1507/endocrine1927.68.3_134. Nihon Naibunpi Gakkai Zasshi. 1992. PMID: 1349867 Review. Japanese.
Cited by
-
Novel Biomarkers in Early Detection of Heart Failure: A Narrative Review.Cureus. 2024 Feb 2;16(2):e53445. doi: 10.7759/cureus.53445. eCollection 2024 Feb. Cureus. 2024. PMID: 38435138 Free PMC article. Review.
-
Exploration of the Potential Biomarker FNDC5 for Discriminating Heart Failure in Patients with Coronary Atherosclerosis.J Cardiovasc Transl Res. 2024 Feb 20. doi: 10.1007/s12265-024-10489-8. Online ahead of print. J Cardiovasc Transl Res. 2024. PMID: 38376700
-
Artificial Intelligence-Enabled Electrocardiography Detects B-Type Natriuretic Peptide and N-Terminal Pro-Brain Natriuretic Peptide.Diagnostics (Basel). 2023 Aug 22;13(17):2723. doi: 10.3390/diagnostics13172723. Diagnostics (Basel). 2023. PMID: 37685262 Free PMC article.
-
Atrial Cardiomyopathy in Valvular Heart Disease: From Molecular Biology to Clinical Perspectives.Cells. 2023 Jul 6;12(13):1796. doi: 10.3390/cells12131796. Cells. 2023. PMID: 37443830 Free PMC article. Review.
-
Aberrant expression of NPPB through YAP1 and TAZ activation in mesothelioma with Hippo pathway gene alterations.Cancer Med. 2023 Jun;12(12):13586-13598. doi: 10.1002/cam4.6056. Epub 2023 May 11. Cancer Med. 2023. PMID: 37165917 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical